|
EP1188055A2
|
|
Laboratory examination of a body fluid or tissue sample
|
|
WO9733578A1
|
|
Combination of cis-4-hydroxy-l-proline and n-methyl-cis-4-hydroxy-l-proline for use as a therapeutic agent, in particular in cancer treatment
|
|
DE3844046A1
|
|
Pharmaceutical compositions which contain isomers of hydroxylysine or lysine
|
|
DE3819870A1
|
|
Pharmaceuticals based on fatty amino alcohols
|
|
EP0299201A2
|
|
Pharmaceutical composition containing a fatty amino-alcohol
|
|
DE3744542A1
|
|
Pharmaceutical use of L-δ-hydroxylysine
|
|
DE3728852A1
|
|
Medicines for tumor therapy
|
|
US4687783A
|
|
Fatty aldehydes and acids in the treatment of neurological and dermatological diseases
|
|
CA1281288C
|
|
Tumor therapy
|
|
DE3518078A1
|
|
MEDICINAL PRODUCTS CONTAINING DERIVATIVES OF PROLIN OR HYDROXYPROLIN
|
|
US4613621A
|
|
Fatty aldehydes and acids in the treatment of neurological and inflammatory diseases
|
|
US4505933A
|
|
Fatty aldehydes in the treatment of Multiple Sclerosis
|
|
CH661207A5
|
|
Pharmaceutical composition containing long-chain aldehydes or carboxylic acids
|
|
GB1153927A
|
|
Medicinal Composition Suitable For Treating Diseases Of The Retina
|
